(no title)
howlgarnish | 5 years ago
But you know who would pay more if they prescribe Lexapro? The manufacturer of Lexapro, and that's who he should have pitched this to. And they have the marketing muscle needed to make it scale.
That said, there's all sorts of conflict of interest/slippery slope issues going down that path, and I'm not sure they would buy this either, but they'd still have been his best bet.
No comments yet.